The spectrum of quality-of-life impairments in recurrent geriatric depression

被引:63
作者
Doraiswamy, PM
Khan, ZM
Donahue, RMJ
Richard, NE
机构
[1] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA
[2] GlaxoSmithKline, N Amer Med Affairs, Hlth Outcomes, Res Triangle Pk, NC USA
[3] GlaxoSmithKline, N Amer Med Affairs, Med Data Sci, Res Triangle Pk, NC USA
来源
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 2002年 / 57卷 / 02期
关键词
D O I
10.1093/gerona/57.2.M134
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background. Although recurrent major depression in elderly individuals is a disabling condition, only a few studies have systematically examined the magnitude and specificity of quality-of-life (QOL) impairments in such patients in comparison with marched controls or the elderly population. Methods. We examined the variations in QOL scores of 100 elderly (age range 60-88 years) patients with moderate to e ere recurrent major depression and compared them with published elderly population norms. Disease-specific Quality of Life in Depression Scale (QLDS) and generic Medical Outcomes Short Form-36 Health Survey (SF-36) QOL ratings obtained at baseline were analyzed. Results. Compared,kith published elderly population norms, depressed subjects showed significant. QOL impairments in five of eight baseline SF-36 items (p <.01). Women rated their QOL as worse than men on physical functioning and role physical (p <.01) and showed similar trends on all other QOL items. Compared with younger subjects, subjects aged older than 70 years reported lower QOL on the summary physical component (p <.05) and a trend for higher QOL on the summary mental component (p <.05) of the SF-36. Depression symptom ratings were correlated with some QOL measures, but accounted for less than 10% of the variance. Conclusions. Despite limitations, such as a cross-sectional design and indirect comparisons with norms generated From another study, our findings confirm the disabling nature of recurrent late-life depression and the importance of targeting both depressive symptoms and broader QOL outcomes in intervention trials.
引用
收藏
页码:M134 / M137
页数:4
相关论文
共 20 条
[1]   Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life [J].
Bondareff, W ;
Alpert, M ;
Friedhoff, AJ ;
Richter, EM ;
Clary, CM ;
Batzar, E .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (05) :729-736
[2]  
Doraiswamy PM, 2001, AM J GERIAT PSYCHIAT, V9, P423
[3]  
Fortner Molly R., 1999, Prim Care Companion J Clin Psychiatry, V1, P174
[4]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[5]  
Heiligenstein J H, 1995, Int Psychogeriatr, V7 Suppl, P125, DOI 10.1017/S1041610295002407
[6]   THE QLDS - A SCALE FOR THE MEASUREMENT OF QUALITY-OF-LIFE IN DEPRESSION [J].
HUNT, SM ;
MCKENNA, SP .
HEALTH POLICY, 1992, 22 (03) :307-319
[7]  
Kuopio AM, 2000, MOVEMENT DISORD, V15, P216, DOI 10.1002/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO
[8]  
2-#
[9]  
Lavretsky H, 1999, AM J GERIAT PSYCHIAT, V7, P309
[10]   Diagnosis and treatment of depression in late life - Consensus statement update [J].
Lebowitz, BD ;
Pearson, JL ;
Schneider, LS ;
Reynolds, CF ;
Alexopoulos, GS ;
Bruce, ML ;
Conwell, Y ;
Katz, IR ;
Meyers, BS ;
Morrison, MF ;
Mossey, J ;
Niederehe, G ;
Parmelee, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (14) :1186-1190